Injectable version of breakthrough Alzheimer’s drug Leqembi shows promising results in study

Biogen president and CEO Chris Viebacher joins 'Squawk Box' to discuss an injectable and more convenient version of the Alzheimer’s drug Leqembi, which showed to be as effective as the currently approved form of the antibody treatment according to initial study results. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi 

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

https://www.cnbc.com/select/best-credit-cards/ 

#CNBC
#CNBCTV 

Видео Injectable version of breakthrough Alzheimer’s drug Leqembi shows promising results in study канала CNBC Television